Publications

  1. Joshi, A., Siddiqui, J., Verma, M., and Chakravorty, M. (1982). Participation of host proteins in the morphogenesis of bacteriophage P22. Molecular and General Genetics. 186: 44-49. PMID: 7050625
  2. 2. Joshi, A., Verma, M., and Chakravorty, M. (1982). Thiolutin resistant mutants of Salmonella typhimurium. Antimicrobial Agents and Chemotherapy. 22: 541-547. PMID: 6758684
  3. Verma, M. and Chakravorty, M. (1985). Hybrid between temperate phage P22 and virulent phage MB78. Biochem. Biophys. Res. Commn. 132: 42-48. PMID: 4062934
  4. Verma, M., Ghosh, B., Chambers, C., Crouch, R.J., and Dutta, S.K. (1985). A ribosomal RNA gene clone isolated from Neurospora crassa wild strain 74A differs significantly from a similar clone isolated from its abnormal developmental slime mutant. Current Science. 54: 1092-1097. www.currentscience.ac.in/.../article_id_054_21_1092_10 www.ias.ac.in/jarch/currsci/.../00001178.pdf‎
  5. Verma, M., Siddiqui, J., and Chakravorty, M. (1985). Bacteriophage P22 helps bacteriophage MB78 to overcome the transcription inhibition in rifampicin resistant mutant of Salmonella typhimurium. Biochemistry International. 11: 77-186. PMID: 3902024
  6. Verma, M., Rao, A.S.M., and Chakravorty, M. (1986). Isolation of temperature sensitive mutants of bacteriophage MB78 and correlation of physical and genetic maps. Virology. 151: 274-285. PMID: 3010554
  7. Verma, M. and Dutta, S.K. (1986). Purification and characterization of enolase from neuroblastoma cell line NG108. Biochemistry International. 13: 555-563. PMID: 3801033
  8. Verma, M., Watson, B., Feelings, A., Coleman, M., and Dutta, S.K. (1986). Relationship of cell growth with neuron specific enolase and acetylcholine esterase activities in human neuroblastoma cells. In: Brain tumors and experimental models. (Dutta, S.K. and Millis, R.M., Ed.) Information Ventures, Inc., Philadelphia. pp 77-83.
  9. Verma, M. and Dutta, S.K. (1987). Phylogenetic implication of heterogeneity of the non-transcribed spacer region of rDNA repeating unit in various Neurospora and related fungal species. Current Genetics. 11: 309-314. PMID: 2834095
  10. Dutta, S.K. and Verma, M. (1987). Isolation and characterization of non-neuronal enolase (NNE) from Neurospora crassa and comparison with neuron specific enolase from neuroblastoma cell line NG108. Biochemistry International. 15: 223-234. PMID:2969242
  11. Dutta, S. K., Verma, Madhu, and Verma, M. (1987). Neurospora crassa nuclear genome contains analogs of Saccharomyces cerevisiae genes for ribosomal RNA processing. Current Genetics. 12: 225-229. PMID: 2835180
  12. Verma, M. and Chakravorty, M. (1987). Bacteriophage MB78 DNA synthesis is specifically inhibited by the chelating agent ethylene diamine tetraacetic acid. FEMS Microbiology Letters. 44: 115-117. DOI:10.1111/j.1574-6968.1987.tb02253.x https://katalog.bib.hs-hannover.de/Record/NLZ239755081
  13. Bailey, J.M., Makheja, A.N., Pash, J. and Verma, M. (1988). Corticosteroids suppress cyclooxygenase messenger RNA level and prostanoid synthesis in cultured vascular cells. Biochem. Biophys. Res. Commn. 157: 1159-1163. PMID: 3144967
  14. Bailey, J.M., Makheja, A.N., Pash, J., and Verma, M. (1989). Regulation of cyclooxygenase messenger RNA levels by EGF and corticosteroids. In: Leukotrines and prostanoids in Health and Diseases. (U. Zor, Ed.). 13: 31-40.
  15. Verma, M. (1989). Effect of spermidine on the development of bacteriophage SP6. Arch Biochem Biophys. 270: 77-83. PMID: 2648998
  16. Verma, M. and Dutta, S.K. (1989). Analysis of DNA sequences containing enhancer DNA sequences. In: DNA Systematics. Vol. III. Mammmals and Higher Primates. (Dutta, S.K. and Winter, W.P., Ed.). CRC Press, Florida. Pp 131-140.
  17. Verma, M. (1989). Improved genomic blot hybridization. Biotechniques. 7: 934. PMID: 2576631
  18. Verma, M. (1989). Use of ammonium sulfate precipitation and guanidine isothiocyanate lysis to isolate lambda DNA. Biotechniques. 7: 230-232. PMID: 2534349
  19. Bailey, J.M. and Verma, M. (1990). Identification of a highly conserved 3' UTR in the translationally regulated mRNA for prostaglandin synthase. Prostaglandins. 40: 585-590. PMID: 2128780
  20. Dutta, S.K., and Verma, M. (1990). Primary structure of the nontranscribed spacer region and flanking sequences of the ribosomal DNA of Neurospora crassa and comparison with other organisms. Biochem. Biophys. Res. Commn. 170: 187-193. PMID: 2142594
  21. Dutta, S.K., Bhattacharya, N., Parui, R., and Verma, M. (1990). Expression of DNA sequences containing neuron specific enolase gene in Escherichia coli. Biochem. Biophys. Res. Commn. 173: 231-239. PMID: 1701632
  22. Bailey, J.M., Makheja, A.N., and Verma, M. (1990). Translation regulation of cyclooxygenase gene expression by glucocorticoids. In: Oxygenases and Oxygen Activation. (Yamamoto, S., Nazaki, M., and Ishimyra, Y., edits.). Kyoto Internationals. Kyoto, Japan, pp 33-36.
  23. Dutta, S.K. and Verma, M. (1991). Implication of DNA systematics in studies of evolution. In: Eukaryotic chromosomes: structural and functional aspects. (Robati, R. and Obe, M., Ed.). pp 11-16. Narosa Publication House. New Delhi.
  24. Dutta, S.K. and Verma, M. (1991). Transcription and processing regulatory sequences of Neurospora crassa ribosomal RNA genes. The Nucleus. 34: 88-95.
  25. Dutta, S.K., Bhansaly, S., Ghosh, B., Chaudhuri, R.K., and Verma, M. (1991). Restriction fragment length polymorphism of rice ribosomal RNA genes. In: Biological Nitrogen Fixation in Rice Production. (Dutta, S.K. and Sloger, C., Ed.). Oxford Publications. pp 377-383.
  26. Bailey, J.M. and Verma, M. (1991). Analytical procedures for a cryptic messenger RNA that mediates translational control of prostaglandin synthase by glucocorticoids. Analytical Biochemistry. 196: 11-18. PMID: 1909509
  27. Dutta, S.K. and Verma, M. (1993). In vivo DNA synthesis of specific genes enhanced by low-dose-rate, 915 MHz CW microwave radiation. In: Electric and Magnetism in Biology and Medicine. (Blank, M., Ed.). San Francisco Press. CA. pp 525-527. https://getinfo.de/app/In-vivo-DNA-synthesis-of-specific-genes-enhanced/id/BLCP%3ACN005446442
  28. Verma, M. and Dutta, S.K. (1993). Enhanced transcription of Neurospora ribosomal RNA genes induced by 915 MHz CW microwave radiation. In: Electricity and Magnetism in Biology and Medicine (Blank, M., Ed.). San Francisco Press. CA. pp 494-496. http://ieee-emf.com/IEEEviewstudy.cfm?accessionNo=1563
  29. Verma, M. and Kurl, R.N. (1993). Human lung enolase: cloning and sequencing of cDNA and its induction with dexamethasone. Biochem. Mol. Biol. Int. 30: 293-303. PMID: 7689884
  30. Dutta, S.K. and Verma, M. (1993). C-myc, c-fos, and c-ras coding sequences are conserved from yeast to mammals. Cancer Biochem. And Biophys.13: 181-185. PMID:8111730
  31. Verma, M. and Dutta, S.K. (1993). Microwave induced alteration in neuron specific enolase gene expression. Cancer Biochem. Biophys. 13: 239-244. PMID: 8521373
  32. Verma, M., Madhu, M., Marrota, C., Lakshmi, C.V., and Davidson, E.A. (1993). Mucin coding sequences are remarkably conserved. Cancer Biochem. and Biophys. 14:  41-51. PMID: 7796387
  33. Verma, M. and Davidson, E.A. (1993). Molecular cloning and sequencing of a canine tracheo-bronchial mucin cDNA containing a cysteine rich domain. Proc. Natl. Acad. Sc. USA. 90: 7144-7148. PMID: 8346228
  34. Verma, M. (1994). Carcinoma associated mucins: molecular biology and clinical applications. Cancer Biochem. and Biophys. 14: 151-162. PMID: 7728736
  35. Verma, M. and Davidson, E.A. (1994). Canine U2 snRNA gene: nucleotide sequence, characterization and implications in RNA processing and cancer biology. Cancer Biochem. and Biophys. 14: 123-131. PMID: 7889492
  36. Verma, M. and Davidson, E.A. (1994). Mucin genes: structure, expression, and regulation. Glycoconjugate J. 11: 172-179. PMID: 7841791
  37. Verma, M. and Dutta, S.K. (1994). Designing of molecular probes to study the effect of EMF in gene activity. In: Biomedical engineering: recent developments. (Vossoughi, J., Ed.) Washington Press, Washington, DC. Pp 1058-1060.
  38. Olnes, M.J., Verma, M., and Kurl, R.N. (1994). 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated gene expression in the immature rat thymus. Exp. Clin. Immunogent. 11: 102-109. PMID: 7826658
  39. Dutta, S.K., Verma, M., and Blackman, C.F. (1994). Frequency dependent alterations in enolase activity in Escherichia coli caused by exposure to electric and magnetic fields. Bioelectromagnetics 15: 377-383. PMID: 7802706
  40. Verma, M. and Dutta, S.K. (1994). DNA sequences encoding enolase are remarkably conserved from yeast to mammals. Life Sc. 55: 893-899. PMID: 7520111
  41. Verma, M., Sanadi, A., and Davidson, E.A. (1994). Mucin synthesis in immortalized canine tracheal epithelial cells. Glycobiology. 4:  825-836. PMID: 7734845
  42. Verma, M., Olnes, M.J., Kurl, R.N., and Davidson, E.A. (1995). Primary structure of the canine U1 snRNA. Gene. 154: 255-257. PMID: 7890173
  43. Verma, M., Blass, C.B., and Davidson, E.A. (1996). Tracheo-bronchial mucin gene expression as detected by in situ hybridization. Glycobiology  6: 141-146. PMID: 8727786
  44. Verma, M., Murthy, V.V.S.,  Mathew, S.,  Banerji, D. ,  Kurl, R.N., Olnes, M.J.,  Yankaskas, J.R., Blass, C.  and Davidson, E. A. (1996). Promoter of the canine tracheo-bronchial mucin gene. Glycoconjugate J. 13: 797-807. PMID: 8910007
  45. Verma, M., Kurl, R.N., Blass, C., and Davidson, E.A. (1997). RNA-RNA interaction and gene splicing. Cancer Biochem. and Biophys. 15: 211-220. PMID: 9224557
  46. Verma, M., Blass, C., and Davidson, E.A. (1997). Upregulation of tracheo-bronchial mucin gene involves cyclic AMP response elements. I. J. Biochem. Biophys. 34: 118-123. PMID: 9343939
  47. Verma, M. and Dutta, S.K. (1996). Transcription initiation and termination sites of ribosomal RNA gene clusters of Neurospora crassa. The Nucleus. 39: 35-42.
  48. Dutta, S.K. and Verma, M. (1996). New directions in genetic therapy research. I. J. Hum. Genetics. 2: 13-18.
  49. Olnes, M.J., Verma, M., and Kurl, R.N. (1996). 2,3,7,8 Tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes. J. Pharmacology and Experimental Therapeutics. 279: 1566-1573. PMID: 8968384
  50. Verma, M and Davidson, E.A. (1997). Transcriptional regulation of tracheo-bronchial mucin gene by ethanol. Gene. 189: 9-12. PMID: 9161404
  51. Gambhir, K.K., Oates, P., Verma, M., Teman, S., and Cheatham, W. (1997). High fructose feeding enhances erythrocye carbonic anhydrase I mRNA levels in rat. New York Acad. Sc. 827: 163-169. PMID: 9329751
  52. Iype, P.T., Iype, L.E., Verma, M., Kaighn, M.E., (1998). Establishment and characterization of immortalized human cell lines from prostatic carcinoma and benign prostatic hyperplasia. International Journal of Oncology. 12: 257-263. PMID: 9458347
  53. Iype, L.E., Michael, M., Verma, M. and Iype, P.T. (1998). Development and characterization of new immortalized human breast cell line. Cytotechnology. 26: 207-218. PMID: 9618944
  54. Dutta, S.K., Nazar, A.S.M.I., and Verma, M. (1998). Enolase activity in chiken embryo primary retina cells is not affected by exposure to a 60-Hz electric field. Cancer Biochem. Biophys. 16: 45-52. PMID: 9923966
  55. Verma, M., Baraniuk, J., Blass, C., Ali, M., Yuta, A., Biedlningmaier, J., and Davidson, E.A. (1999). CFTR antisense phosphorothioate oligodeoxynucleotides (S-ODNs) induce tracheo-bronchial mucin (TBM) mRNA expression in human airways mucosa. Glycoconjugate Journal. 16: 7-11. PMID: 10580645
  56. Banerjee, H.N., Verma, M., Hou, L.H., Ashraf, M., and Dutta, S.K. (1999). Cytotoxicity of TNT and its metabolites. Yale Journal. of Bio. Med. 72: 1-4.
  57. Verma, M. and Davidson, E.A. (1999). MUC1 upregulation by ethanol. Cancer Biochemistry and Biophysics. 17: 1-11. PMID: 10738897
  58. Banerjee, H.N. and Verma, M. (2000). Search for a novel killer toxin in yeast Pichia pastoris. Plasmid. 43: 181-183. PMID 10686140
  59. Srivastava, S.K., Verma, M., and Henson, D. (2001). Biomarkers for early detection of colon cancer. Clinical Cancer Research. 7: 1118-1126. PMID:11350874
  60. Verma, M. and Srivastava, S.K. (2001). Enzyme immunoassay. In: Encyclopedia of Public Health, Elly Dickson, Publisher. New York, NY. (http://www.enotes.com/public-health-encyclopedia/enzyme-immunoassay )
  61. Verma, M., Wright, G. L., Hanash, S.M., Gopal-Srivastava, R., and Srivastava, S. (2001). Proteomic approaches within the NCI Early Detection Research Network for the discovery and identification of cancer biomarkers. Anals. New York Acad. Sc. 945:103-115. PMID: 11708463
  62. Verma, M., Srivastava, S.K., and Henson, D. (2001). Infectious agents and human cancer: implications for cancer prevention and treatment. Research Advances in Cancer. 1: 47-53.
  63. Verma, M., Lambert, P., and Srivastava, S.K. (2001). Meeting Highlights: National Cancer Institute Workshop on Molecular Signatures of Infectious Agents-Challenges in Development of Detection Technology and Prevention Strategies. Disease Markers. 17: 191-201. DOI:10.1155/2001/986049 PMID:11790886
  64. Verma, M. and Srivastava, S. (2001). Molecular Signatures of Infectious Agents in Human Cancer. Disease Markers. 17: 121-123. http://prevention.cancer.gov/files/news-events/20000907.pdf
  65. Verma, M., Negm, R., and Srivastava, S.K. (2002). The NCI EDRN approach to molecular targets for earlier cancer detection and identification of risk. Journal of Clinical Ligation Assay. 25: 6-10.
  66. Negm, R., Verma, M., and Srivastava, S. (2002). The promise of biomarkers in cancer screening and detection. Trends in Molecular Medicine. 8: 288-293. PMID: 12067615
  67. Srinivas, P., Verma, M., Zhao, Y., and Srivastava, S. (2002). Proteomics for cancer biomarkers discovery. Clinical Chemistry. 48: 1160-1169. PMID: 12142368
  68. Verma, M. (Editor). (2002). Molecular Signatures of Infectious Agents in Cancer. IOS Press. Amsterdam. Netherland. ISBN: 978-1-58603-250-0  http://www.iospress.nl/book/molecular-signatures-of-infectious-agents-in-cancer/
  69. Verma, M. and Srivastava, S.  (2002). Epigenetics in Cancer:  Implications for Early Detection and Prevention. Lancet Oncology. 3, 755-763. PMID: 12473517
  70. Verma, M. and Srivastava, S. (2003). New cancer biomarkers deriving from the early cancer detection research. In: Tumor Prevention and Genetics (Senn, H.J. , Mortan, R., edt). Springer Press, Berlin, Germany. Pp72-84. Recent Results in Cancer Research. 163, 72-84. PMID:12903844
  71. Verma, M., Dunn, B., and Umar, A. (2003) (Ed.). Epigenetics in cancer prevention. Annals of New York Academy of Sciences. NY. PMID:12724207
  72. Verma, M. (2003). Viral genes and methylation. Annals of New York Academy of Sciences. 983, 1-11. PMID:12724222
  73. Verma, M., Dunn, B. D., Ross, S., Jain, P., Wang, W., Hayes, R., and Umar, A. (2003). Proceedings of the workshop on epigenetics in cancer prevention: early detection and risk assessment. Annals of New York Academy of Sciences. NY. 983, 298-319. PMID: 12724234
  74. Rajeevan, M. S., Dimulescu, I. M., Vernon, S. D., Verma, M., and Unger E. (2003). Global amplification of sense RNA: a novel method to replicate and archive mRNA for gene expression analysis. Genomics 82, 491-497. PMID:13679029
  75. Verma, M., Kagan, J., Sidransky, D., and Srivasatava, S. (2003). Proteomic analysis of the cancer cell mitochondria. Nature Reviews: Cancer 3, 789-795. PMID: 14570046
  76. Habis, A. H., Vernon,S. D., Lee, D.R., Verma, M., Srivastava, S., and Unger, U. (2004). Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiology Biomarkers and Prevention. 13, 492-496. PMID: 15006929
  77. Verma, M., Maruvada, P., and Srivastava, S. (2004). Current approaches in mitochondrial proteomics. MitoMatters. 3: 3-5.
  78. Ravichandran, R. , Vasquez, G. B., Srivastava, S., Verma, M., Petricoin, E., Lubell, J., Sriram, R. D., Barker, P. E., Gilliland, G. L. (2004). Data Standards for Proteomics: Mitochondrial two-dimensional Polyacrylamide Gel Electrophoresis Data as a Model System. Mitochondrion  3: 327-336. PMID:16120364
  79. Wagner, P.D., Verma, M., and Srivastava, S. (2004). Challenges for biomarkers in cancer detection. New York Acad. Sc. 1022: 9-16. PMID: 15251933
  80. Grizzle, E. , Adam, B., Bigbee, W. L.,  Conrads, T. P., Carroll, C., Feng, Z., Izbicka, E., Jendoubi, M.,  Johnsey, D. , Kagan, J., Verma, M.,  Leach, R.; McCarthy, D. B.; Semmes, O. J.; Srivastava, S.;  Srivastava, S.;  Thompson, I. M.; Thornquist, M.D.; Zhen, Z.; Zhiqiang,  Z.; (2004). Serum Protein Expression Profiling for Cancer Detection: Validation of a SELDI-based Approach for Prostate Cancer. Disease Markers. 19: 185-195. PMID: 15258333
  81. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. (2004). Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun. 316:1156-62. PMID:15044106
  82. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R. (2004). CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Research. 64: 5956-5962. PMID:15342374
  83. Verma, M. (2004). Biomarkers for risk assessment in molecular epidemiology of cancer. Tech. Cancer. Res. Treatment. 3: 505-514. PMID: 15453816
  84. Verma, M., Maruvada, P., and Srivastava, S. (2004). Epigenetics and cancer. In: Critical Reviews in Clinical Sciences. 41: 585-607. PMID: 15603512
  85. Banerjee, H.N., Verma, M., and Dutta, S.K. (2004). 2-Am,4,6-DNT causes genotoxicity of p53 gene in NG108 neuroblastoma cell lines. Int. J Hum. Genet. 4: 227-229. http://www.krepublishers.com/02-Journals/IJHG/IJHG-04-0-000-000-2004-Web/IJHG-04-4-227-294-2004-Abst-PDF/IJHG-04-4-227-229-2004-Banerjee-H-N/IJHG-04-4-227-229-2004-Banerjee-H-N.PDF
  86. Srivastava, S. and Verma, M. (2005). Proteomics Technologies and Informatics. In: Informatics in Proteomics (Srivastava, S. ed.). CRC Press. Pp. 17-30.
  87. Verma, M. and Srivastava, S. (2005). Biomarkers in cancer detection and risk assessment. In: Genome and Proteome in Oncology” (Ed. Tzortzatou-Stathopoulou, F.) (Chapter 14. Nova Science Publishers, Inc. (www.novapublishers.com). Pp 257-273.
  88. Kaneuchi, M., Sasaki, M., Tanaka, Y., Shiina, H., Yamada, H., Yamamoto, R., Sakuragi, N., Enokida, H., Verma, M.  and Dahiya, R. (2005). WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer. 104:1924-30.
  89. Verma, M. and Srivastava, S. (2005). Implications of epigenetics for early cancer diagnosis and prevention. In: Cancer Drug Discovery and Development, The Oncogenomics Handbook (W. J. LaRochelle, R. A. Shimkets, edts.). Humana Press Inc., Totowa, NJ. (http://www.humanapress.com/index.php).
  90. Srivastava, S., Verma, M., and Gopal-Srivastava, R. (2005). Proteomic maps of the cancer-associated infectious agents. J. Proteome Research. 4: 1171-1180. PMID:16083267
  91. Verma, M. (2005). Pancreatic cancer epidemiology. Tech. Cancer Res. Treatment. 4: 295-302.
  92. Verma M, Kagan J, Srivastava S. DNA in neoplastic disease diagnosis. In: Robert A. Meyers ed.(2005). Encyclopedia of Molecular Cell Biology and Molecular Medicine, Volume 9, Mutagenesis, Malignancy and Genome Instability to Organic Cofactors as Coenzymes. WeinHeim, Germany: John Wiley & Sons, Inc., Weinheim, Germany, 2005, pp. 634.
  93. Thamire, C., Divi, R.L, and Verma, M. (2005). A theoretical comparison of the efficiency of microwave and ultrasound applicators used in transurethral thermal therapy. Proceedings of American Society of Mechanical Engineering, 72674, 1-9.
  94. Verma, M., Seminara, D., Arena, J. F., John, C., Iwamoto, K., and Hartmuller, V. (2006). Genetic and epigenetic biomarkers in cancer: improving diagnosis and risk assessment. Molecular Diagnosis and Therapy 10: 1-15. PMID:16646573
  95.  Banerjee HN, Verma M. (2006). Use of nanotechnology for the development of novel cancer biomarkers. Expert Rev Mol Diagn. 6:679-683. PMID: 17009903
  96. Kumar, D. and Verma, M. (2006). Molecular markers of cervical squamous cell carcinoma. CME Journal of Gynecologic Oncology. 11: 41-60.
  97. Verma, M. and Manne, U. (2006). Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations. Crit. Rev. Hematol. Oncol. 60:9-18. PMID: 16829121
  98. Banerjee, H.N. and Verma, M. (2007). Tumor suppressor genes. In: Tumor Suppressor Genes (Polanski, K., edt.). Nova Publishers. Hauppauge, NY. pp. 19-33.
  99. Verma, M., Naviaux, R., Tanaka, M., Kumar, D., Franceschi, C., and Singh, K. (2007). Mitochondrial DNA and cancer epidemiology. Cancer Research. 67:437-439.
  100. Chauhan, S.C., Kumar, D., Bell, M.C., Koch, M.D., and Verma, M. (2007). Molecular markers of miscellaneous primary and metastatic tumors of the uterine cervix. Eur. J. Gynaec. Oncol. XXViii: 5-14. PMID: 17375698
  101. Verma, M. and Kumar, D. (2007). Application of mitochondrial genome information in cancer epidemiology. Clin. Chimica Acta. 383: 41-50. PMID: 17532310
  102. Verma, M. and Kumar, D. (2008) Mitochondrial DNA. In: Encyclopedia of Cancer, 2nd Edition. Springer Publications. Germany.
  103. Banerjee, H. N. Verma, M. (2008). Application of nanotechnology in cancer. Technol. Cancer. Res. Treat. 7:149-154. PMID:18345704
  104. Ross, S. A., Dwyer, J., Umar, A. Kagan, J., Verma, M., Bemmel, D.V., and Dunn, B.K. (2008) Diet, Epigenetic Events and Cancer Prevention. Nutrition Reviews. 66: S1-S6.
  105. Verma, M. and Kumar, D. (2008). Diagnosing cancer using histone modification analysis. In: Cancer Epigenetics (Tollefsbol, T. ed.). CRC Press, New York. Pp 347-457.
  106. Kumar, D. and Verma, M. (2009). Methods in cancer epigenetics and epidemiology. In: Cancer Epidemiology: Host Susceptibility Factors (Verma, M, edt.). Humana Press. Methods in Mol. Biol. 471: 473-488. doi: 10.1007/978-1-59745-416-2_14. PMID:19109785
  107. Verma, M. (2009). Proteomics and cancer epidemiology. In: Cancer Epidemiology: Host Susceptibility Factors (Verma, M, edt.). Humana Press. Methods in Mol. Biol. 471: 197- 215.
  108. Chauhan, S.C., Jaggi, M., Bell, L.C., Verma, M., and Kumar, D. (2009). Epidemiology of human papilloma virus (HPV) in cervical mucosa. In: Cancer Epidemiology: Host Susceptibility Factors (Verma, M, edt.). Humana Press. Methods in Mol. Biol. 471: 439-456.
  109. Verma, M. (2009). Human epigenome and cancer. In: Human Genome Epidemiology, 2nd Edn. (Muin Khoury, Sara Bedrosian, Marta Gwinn, Julian Higgins, John Ioannidis and Julian Little Khoury, M. eds.), Oxford University Press. Pp 551-578.
  110. Banerjee, H. N. and Verma, M. (2011) Quantum dots and their application in cancer detection and therapy. International Journal of Biomedical Science and Nanotechnologies (IJBNN). 2: 33-43.
  111. Banerjee, H.N., and Verma, M. (2009). Epigenetic mechanisms in cancer. Biomark Med. 3: 397-410. doi: 10.2217/bmm.09.26.PMID: 20477485
  112. Mishra, A. and Verma, M. (2010). Cancer biomarkers: are we ready for the prime time? Cancers, 2: 190-208.
  113. Verma, M. (2010). Pancreatic cancer biomarkers and their application in cancer diagnosis and epidemiology. Cancers, 2: 1830-1837.
  114. Verma, M. (2010). Nutritional epigenetics and disease prevention: are we there yet? In: Nutrition, Epigenetic Mechanisms and Human Disease (Maulik N. and Maulik, M., edt.). CRC Press. New York. Pp 1-11.
  115. Kumar, D., Srivastava, A., Chauhan, S.C., and Verma, M. (2011). MicroRNAs in gynecological cancers. In: Current Advances in Gynecology Oncology. (Chauhan, S.C, Kumar, D., Juggi, M., Bell, M.C., edts.). ISBN Press. New York.pp 81-91.
  116. Verma, M., and Kumar, D. (2011). Environmental factors and gynecological cancer. In: Current Advances in Gynecology Oncology. (Chauhan, S.C, Kumar, D., Juggi, M., Bell, M.C., edts.). ISBN Press. New York. 109-118.
  117. Chauhan, S.C.., Kumar, D., Bell, M.C., Verma, M., and Jaggi, M. (2011) Current Trends in Ovarian Cancer Diagnostics and Therapeutics. “Current Advances in Gynecological Oncology” Editor(s): Dr. Subhash C. Chauhan and Deepak Kumar, Co-editors: Meena Jaggi and Maria C. Bell. Research Signpost Publications, PP 1-28
  118. Patacsil, D., Osayi, S., Tran, A.H., Saenz, F., Yimer, L., Shajahan, A. N., Gokhale, P. C.; Verma, M., Clarke, R., Chauhan, S. C.; and Kumar, D. (2011). Vitamin E succinate inhibits survivin and induces apoptosis in pancreatic cancer cells. Genes and Nutrition.7:  83-89.
  119. Verma, Mukesh, Patel, Payal., and Verma, Mudit (2011). Biomarkers in prostate cancer epidemiology. Cancers, 3: 3373-3378.
  120. Divi, R.L., Luch, A., Verma, M. and Mahadevan, B. (2012). CYP1B1 Detection. Current Protocols in Toxicology. 4: 4.38.
  121. Verma, M. (2012). Personalized medicine and cancer. J. Pers. Med. 2: 1-14. http://www.mdpi.com/2075-4426/2/1/1
  122. Verma, M. (2012). Epigenetic biomarkers in cancer epidemiology. Methods Mol Biol. 863: 467-480. PMID: 22359311 http://www.springer.com/biomed/cancer/book/978-1-61779-611-1
  123. Banaudha, K.K., Verma, M. (2012). The role of miRNA in the management of liver cancer. Methods Mol Biol. 863: 241-251. PMID: 22359297
  124. Khare, S., Verma, M. (2012). Epigenetics of colon cancer. Methods Mol Biol. 863: 177-185. PMID: 22359293
  125. Mishra, A., Verma, M. (2012). Epigenetics of solid cancer stem cells. Methods Mol Biol. 863: 15-31. doi: 10.1007/978-1-61779-612-8_2. PMID: 22359285 http://www.springer.com/biomed/cancer/book/978-1-61779-611-1
  126. Verma, M. (2012). Research opportunities for metabolomics at NIH. J. Proteomics and Bioinformatics. 5: 2-3.
  127. Verma, M. (2012). Cancer control and prevention by nutrition and epigenetic approaches. Antioxid Redox Signal. 17: 355-364. doi: 10.1089/ars.2011.4388. Epub 2012 Jan 30. Review. PMID: 22047027
  128. Khoury MJ, Freedman AN, Gillanders EM, Harvey CE, Kaefer C, Reid BC, Rogers S, Schully SD, Seminara D, Verma M. (2012). Frontiers in cancer epidemiology: a challenge to the research community from the epidemiology and genomics research program at the national cancer institute. Cancer Epidemiol Biomarkers Prev. 21: 999-1001. doi: 10.1158/1055-9965.EPI-12-0525. Epub 2012 Jun 4. PMID: 22665580
  129. Verma, M. (2012). Epigenome-wide association studies (EWAS) in cancer. Current Genomics, 13: 308-313. PMID: 23204920
  130. Verma, M. and Banaudha, K. (2012).  Application of cancer toxocoepigenomics in identifying high risk populations. In: Toxicology and Epigenetics (Sahu, S.C. editor). John Wiley and Sons, Ltd. Publications. Pp 645-652. ISBN: 9781119976097 (hardback)
    111997609X (hardback). LCCN: 2012010175. NLM ID: 101595585 [Book]
    http://onlinelibrary.wiley.com/doi/10.1002/9781118349045.ch33/summary DOI: 10.1002/9781118349045.ch33
  131. Dumitrescu, R.G. and Verma, M. (2012).Cancer epigenetics: methods and protocols. (editors). Springer Protocols. Humana Press. New York. Pp 1-490. NLM ID: 101590251. ISBN: 9781617796111. LCCN: 2012931559
  132. Verma, M., Khoury, M. J., and Ioannidis, P.A. (2013). Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiology Biomarkers and Prevention 22: 189-200. PMID: 23242141
  133. Verma, M. (2013). Cancer control and prevention: nutrition and epigenetics. Curr. Opin. Nutr metab Care. 16: 376-384. DOI:10.1097/MCO.0b013e328361dc70
  134. Verma, M. (2013). Nutracutical-gut microbiome interactions in human disease. In. Neutraceuticals and Health: Review of Human Evidence (Mahabir, Somdat, and Pathak, Yashwant, edts.). CRC Press, NY. Pp 243-252. http://www.crcpress.com/product/isbn/9781466517226
  135. Vedham, V., Divi, R.L., Starks, V.L., and Verma, M. (2013).  Multiple infections and cancer: implications in epidemiology. Tech. Cancer Res. and Treatment 13: 177-194. DOI: 10.7785/tcrt.2012.500366. ISSN 1533-0346. Aug. 2 2013. PMID: 23919392
  136. Zhang, Q., Verma, M., and Khare S. (2013). Epigenetic regulation of microRNA in colon cancer. In: Epigenetics and Cancer (Sarkar, F.H., editor). Springer Press. New York. Pp 85-94. DOI 10.1007/978-94-007-6612-9_5
  137. Verma, M., Agarwal, N., and Verma, M. (2014). Epigenetics and animal models: applications in cancer control and treatment. In: “Animal Biotechnology” (Verma, A. and Singh, A, edts). Elsevier Inc. pp. 57-72. Animal Biotechnology. http://dx.doi.org/10.1016/B978-0-12-416002-6.00004-3
  138. Verma, M., Rogers, S., Divi, R.L., Schully, S.D., Nelson, S., Su, L.1, Ross, S.A., Pilch, S., Winn, D.M., Khoury, M.J.  (2014). Epigenetic Research in Cancer Epidemiology: Trends, Opportunities, and Challenges. Cancer Epidemiology Biomarkers and Prevention: 23: 223-233. PMID: 24326628. DOI 10.1158/1055-9965.EPI-13-0573
  139. Verma, M. (Co-editor) (2014). "Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis". Editors: Debmalya Barh , Angelo Carpi , Mukesh Verma , and Mehmet Gunduz. CRC Press 2014. E-book ISBN 978-1-4665-8429-7
    The e-Book can be accessed from: http://www.crcnetbase.com/isbn/9781466584297
  140. Verma, M., Agarwal, N., and Verma, M. (2014). Mitochondria DNA in early cancer diagnosis and screening (Chapter 6). In: "Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis". Editors: Debmalya Barh , Angelo Carpi , Mukesh Verma , and Mehmet Gunduz. CRC Press 2014. Pp. 95-114. E-book ISBN 978-1-4665-8429-7. The e-Book can be accessed from: http://www.crcnetbase.com/isbn/9781466584297. pp 95-114. Print ISBN. 978-1-4665-4828-0 . DOI: 10.1201/b16389-8
  141. Verma, M., Barh, D., Jain, N. (2014). Noninvasive early markers in lung cancer. (Chapter 10). In: "Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis". Editors: Debmalya Barh , Angelo Carpi , Mukesh Verma , and Mehmet Gunduz. CRC Press 2014. Pp 415-431. E-book ISBN 978-1-4665-8429-7. The e-Book can be accessed from: http://www.crcnetbase.com/isbn/9781466584297. pp 95-114. Print ISBN. 978-1-4665-4828-0 . DOI: 10.1201/b16389-8
  142. Majda Haznadar, Eliza Mette, Padma Maruvada, John Milner, Steven C. Moore, Holly L. Nicastro, Joshua N. Sampson, Mukesh Verma, L. Joseph Su, and Krista A. Zanetti (2014). Navigating the Road Ahead: Addressing Challenges for Use of Metabolomics in Epidemiology Studies. Metabolomics. 10: 176-178.  DOI 10.1007/s11306-014-0636-z
  143.  Verma, M. and Barh, D. (2014). Breast cancer biomarkers for risk assessment, screening, detection, diagnosis, and prognosis. Chapter 20. In D. Barh (ed.). Omics Approaches in Breast Cancer: Toward nest generation Diagnosis, Prognosis, and Therapy. Pp 2-17. Springer Press. http://www.springer.com/medicine/oncology/book/978-81-322-0842-6
Invited Speaker/Session Chair/Moderator
  • Invited to give a talk on “Tracheobronchial mucin gene transcription in lung cancer” at the 2nd International Conference on CANCER ASSOCIATED MUCINS, Cambridge, UK. (Aug. 2-6, 1992) (Host: Dr. Sandra Gendler)
  • Invited by Gibco/BRL Life Technologies, Inc., Gaithersburg, MD for a talk on " Tracheo-bronchial mucin cDNA" (June 27, 1995) (Host: Dr. Lawrence Mertz)
  • Invited by Merck Frosst, Montreal, Canada for a lecture on "Transcriptional regulation of tracheo-bronchial mucin gene" (July 24, 1995) (invitation from Dr. Jilly Evans)
  • Invited speaker in 4th International Symposium on Biological Role of Cell Surface Molecules, New Delhi, India. (Jan 6-10, 1996) (Host: Dr. B.K.Bachawat). Title of talk: Upregulation of tracheo-bronchial mucin gene involves cAMP response elements
  • Invited by SmithKline Beecham, King of Prussia, PA, for a talk on "Involvement of cyclic AMP response elements in up-regulation of tracheal mucin gene" (Dec. 21, 1995) (Host: Dr. Paul C Hiebel)
  • Invited by Biotech Research Laboratory, Rockville, MD to give a talk on "Transcriptional regulation of tracheo-bronchial mucin gene" (Host: Dr. I. Gonvalez) (June, 1996)
  • Invited by Pfizer and SmithKline for a talk in Pulmonary Research Group Symposium (King of Prussia, PA; September 26, 1996), (Host: Dr. Claudia Turner of Pfizer and Dr. Mary Barnette of SmithKline
  • Invited by ASOIO (American Scientists of Indian Origin) to present my work on "Gene therapy of airways diseases" in Bethesda, MD (Feb. 7, 1999)
  • Invited speaker in a workshop on “Nanotechnology in Cancer Research” in Washington, DC (October, 2000)
  • Invited panelist in the “Linking Haplotypes and Genetic Variation with Cancer Risk Assessment, Detection, Prevention, and Treatment” workshop in Bethesda, MD (Dec. 4-5, 2003)
  • Invited speaker in an international conference on “Molecular Diagnostics in Cancer” in San Francisco, CA (March 23-26, 2004)
  • Speaker in the “First NCI Epidemiology Leadership Workshop”. (September 19-21, 2004; Chicago, IL) Title: Opportunities in Epigenetics.
  • Speaker in the “25th Annual Convention of the Indian Association of Cancer Research” to talk about “Epigenetic Approaches in Cancer Control and Epidemiology” held at the Advanceed Center for the Treatment, Research and Education in Cancer, Tata Memorial Center, Mumbai, India (Feb. 15-18, 2006) (Host: Dr. Rajiv Sarin, Director, ACTREC)
  • Speaker at the National Institute of Immunology (NII), New Delhi, India to talk about Epigenetics and Cancer (Feb. 20, 2006) (Host: Dr. J. K. Batra)
  • Speaker at the Institute of Cytology and Preventive Oncology (ICPO) at Noida, New Delhi. India to give a talk on “Epigenetics and Cancer” (Feb. 21, 2006) (Host: Dr. B. C. Das, Director, ICPO)
  • Invited by the “Translational Research in Clinical Oncology” NIH to give a lecture on “Cancer Epigenetics” (Host: Dr. Terry Moody, November 6, 2006)
  • Invited by the Center for Prostate Disease Research, Department of Defense to give a talk on “Prostate Cancer Research in EGRP” (Host: Dr. Jennifer Cullen, Director, Multi-center National Database; December 6, 2006)
  • Invited by the Department of Clinical Oncology, All India Institute of Medical Sciences, New Delhi, India to give a talk on “Epigenetic Approaches in Cancer Control” (Host: Dr. Lalit Kumar. Jan.18, 2007)
  • Invited by the Industrial and Toxicology Institute (ITRC), Lucknow, India to give a talk on “Environmental Carcinogens and Epigenetics ” (Host: Dr. Alok Dhawan and Dr. Sushil Kumar. Jan.19, 2007)
  • Invited by the Central Drug research Institute, CDRI, Lucknow, India to give a talk on “Cancer Biomarkers” (Host: Dr. C.M. Gupta, Director CDRI. Jan.19, 2007)
  • Invited by the Sanjay Gandhi Medical Institute (SGPGI), Lucknow, India to give a talk on “Cancer Epigenetics” (Host: Dr.Balraj Mittal. Jan.19, 2007)
  • Invited by the Center of Cellular and Molecular Biology, Hyderabad, India to give a talk on “Mitochondrial DNA in Identifying Populations with High-risk of Developing Cancer” (Host: Dr. K. Thangraj, January 22, 2007)
  • Chaired the Session on “Cancer and Toxicity” in the “Indo-US Workshop on MITOCHONDRIAL RESEARCH AND MEDICINE”, Hyderabad, India (January 22-24)
  • Invited by the National Institute of Nutrition (NIN), Hyderabad, Hyderabad, India to give a talk on “Cancer Epigenetics and Diet” (Host: Dr. S. Sesikeran, Director NIN, January 22, 2007)
  • Invited by the Institute of Pathology (IOP), New Delhi, India to give a talk on “Epigenetics Approaches in Cancer Control” (Host: Dr. Sunita Saxena, Director IOP. Jan.18, 2007)
  • Speaker at the Institute of Cytology and Preventive Oncology (ICPO) at Noida, New Delhi. India, to give a talk on “Cohort Consortia in Cancer Research” (Jan. 27, 2006) (Host: Dr. B. C. Das, Director, ICPO).
  • Keynote Speaker in “International Symposium on the Predictive, Preventive, and Mechanistic Mutagenesis and the XXXIII Annual Meeting of the Environmental Mutagenesis Society” organized by Aligarh University at Aligarh, New Delhi, India from January 1-3, 2008. Topic of the talk: “Environmental Influences on Cancer Epigenetics.” (Host (Prof. Javed Musarrat)
  • Speaker at the 3rd International Symposium on Mitochondria (Bethesda, MD; Jan 9-11, 2008). Topic of the talk: “Research Opportunities at National Cancer Institute: Using Mitochondrial Genomic and Proteomic Information.”
  • Speaker at the GEI workshop on “Omics” Technologies. Howard University. Washington, DC. March 25, 2008. Topic: Genome-Wide Association Studies and Cancer Epigenetics. (Host: Prof. S. K. Dutta).
  • Chaired a session on “The potential for epigenetics diagnosis and therapy” in a workshop on “Emerging evidence for epigenomics in human diseases” during the NIH Epigenome Roadmap meeting (March 16-17, 2009)
  • Invited Speaker in the AFRRI seminar series (Organizer: Dr. Vijay K. Singh) on “Epigenetics in cancer epidemiology” May 1, 2009.
  • Invited Speaker in the PUBLIC HEALTH GENOMICS seminar series (Organizer: Muin Khoury) on “Epigenetics in disease control and prevention: When will it be ready for prime time?” August 26, 2009.
  • Invited Speaker in the Environmental Mutagenesis Society (EMS) annual meeting to give a talk on “NCI funding opportunitiesin cancer epidemiology” October 24, 2009.
  • TRACO (Translational Research in Clinical Oncology) lecture: due for November 23, 2009, on EPIGENETICS (only 2 more NCI extramural staff have been invited for this NIH vide lecture series which is video cast).
  • Invited Speaker in the VI International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, to give a talk on “Epidemiology biomarkers isolated from biofluids” (November 8-10, 2009).
  • Invited Speaker to participate and provide comments on policies related with data sharing and biospecimen sharing in the International Human Epigenome Consortium (IHEC) (Paris, Jan 25-26, 2010) (represented NCI in the IHEC).
  • Invited Speaker in Japanese Society of Epigenetics (Yonago, Japan) about NIH Epigenome Roadmap.
  • Invited Speaker by the National Cancer Center, Tokyo to give a talk on “How NCI Funds Research” (Host: Kazu Ushijima (May 27, 2010).
  • TRACO (Translational Research in Clinical Oncology) lecture: due for November 22, 2010, on EPIGENETICS (only 2 more NCI extramural staff have been invited for this NIH vide lecture series which is video cast) (Invitation from TRACO Chair Terry Moody).
  • Invited by University of Maryland, School of Public Health to give a talk on “Epigenetic approaches in cancer epidemiology and risk assessment” (Host: Dr. M. Lee).March 31, 2011.
  • Invited by NIH-India Group to give a talk on “Epigenetics in Cancer Control and Prevention: Are we ready for the prime time?” (Host Dr. Manoj Tyagi). May 19, 2011.
  • Invited by National Institute of Pathology, New Delhi, India, to give a talk on “Epigenetics in cancer control: are we there yet?” (December 19, 2011).
  • Invited by University of Vanderbilt to give a talk on “Epigenetic in cancer control and therapy” (Host: Dr. Anil Shankar). Feb. 24, 2012.
  • Invited to give a talk in METABOLOMICS AND SYSTEMS BIOLOGY meeting in the keynote forum on “Metabolomic approaches in cancer epidemiology and risk assessment” Feb. 22, 2012.
  • Invited by PRESTO (Program and Review Extramural Staff Training Office” to give a talk on “GWAS and EWAS of Cancer: Recent advances and Funding Overview” (Nov. 2012).
  • Invited by FDA to give a talk on “Toxicoepigenomics in Cancer” (October 2012).
  • Invited by Mayo Clinic to give a talk on “Epigenetic regulation of Angiogenesis” during the 5th Mayo Clinic Symposium on Angiogenesis: Angiogenesis and Tumor Microenvironment.
  • Invited by the NCI Translational Research Clinical Oncology (TRACO) group to give a talk on “Cancer Epigenetics” (November 15, 2012).

Edited Books
Edited three books:

  • “Cancer Epigenetics” (Humana Press) (2012)
  • “Cancer Epidemiology” (Humana Press) (This book has two volumes: Volume 1 : Host Susceptibility Factors; Volume 2: Modifiable Risk Factors) (2009)
  • “Epigenetics and Cancer Prevention” (New York Academy of Sciences) (2003)
  • “Molecular Signatures of Infectious Agents in Cancer” (Special Issue of Disease Markers, IOL Press) (2006)

 

Mukesh Verma

Program Director, Epidemiology and Genomics Research Program

:(240) 276-6889
Fax: (240) 276-7921

  • DEPARTMENT Division of Cancer Control and Population Sciences
    National Cancer Institute
    National Institutes of Health
  • COUNTRY USA